Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Organ Transplantation | 60 | 2024 | 1172 | 10.620 |
Why?
|
Cytomegalovirus Infections | 34 | 2024 | 838 | 9.510 |
Why?
|
Kidney Transplantation | 41 | 2024 | 4278 | 5.570 |
Why?
|
Cytomegalovirus | 22 | 2024 | 754 | 4.460 |
Why?
|
Immunocompromised Host | 25 | 2024 | 865 | 3.080 |
Why?
|
Antiviral Agents | 31 | 2024 | 3070 | 2.980 |
Why?
|
Tissue Donors | 26 | 2023 | 2392 | 2.130 |
Why?
|
Medical Tourism | 5 | 2021 | 51 | 2.000 |
Why?
|
Communicable Diseases | 13 | 2023 | 872 | 1.960 |
Why?
|
BK Virus | 3 | 2024 | 120 | 1.820 |
Why?
|
Respiratory Syncytial Virus Vaccines | 5 | 2024 | 37 | 1.750 |
Why?
|
Polyomavirus Infections | 2 | 2024 | 193 | 1.580 |
Why?
|
Tumor Virus Infections | 3 | 2024 | 438 | 1.570 |
Why?
|
Parasitic Diseases | 4 | 2013 | 76 | 1.520 |
Why?
|
Liver Transplantation | 10 | 2022 | 2416 | 1.390 |
Why?
|
Respiratory Syncytial Virus Infections | 5 | 2024 | 366 | 1.260 |
Why?
|
Opportunistic Infections | 6 | 2018 | 376 | 1.230 |
Why?
|
Vaccines | 6 | 2022 | 842 | 1.220 |
Why?
|
Hematopoietic Stem Cell Transplantation | 14 | 2023 | 5753 | 1.190 |
Why?
|
Immunosuppressive Agents | 15 | 2024 | 4215 | 1.170 |
Why?
|
Travel Medicine | 5 | 2019 | 83 | 1.100 |
Why?
|
Virus Diseases | 5 | 2015 | 720 | 1.050 |
Why?
|
Acetates | 4 | 2023 | 314 | 1.050 |
Why?
|
Donor Selection | 6 | 2024 | 242 | 1.030 |
Why?
|
Dermatomycoses | 3 | 2011 | 45 | 0.990 |
Why?
|
Kidney Failure, Chronic | 4 | 2022 | 2505 | 0.970 |
Why?
|
Tissue and Organ Procurement | 8 | 2021 | 987 | 0.930 |
Why?
|
Pyelonephritis | 1 | 2024 | 77 | 0.920 |
Why?
|
Lung Transplantation | 5 | 2022 | 1310 | 0.900 |
Why?
|
Herpesviridae Infections | 2 | 2022 | 268 | 0.830 |
Why?
|
Vaccination | 13 | 2024 | 3434 | 0.810 |
Why?
|
Immunity, Cellular | 4 | 2022 | 1560 | 0.810 |
Why?
|
Travel | 5 | 2024 | 806 | 0.800 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2024 | 239 | 0.790 |
Why?
|
Blood Donors | 1 | 2024 | 344 | 0.790 |
Why?
|
Measles | 1 | 2024 | 180 | 0.780 |
Why?
|
Consensus | 7 | 2024 | 3208 | 0.750 |
Why?
|
Respiratory Syncytial Virus, Human | 4 | 2024 | 150 | 0.730 |
Why?
|
Influenza A Virus, H1N1 Subtype | 4 | 2012 | 453 | 0.710 |
Why?
|
Herpesvirus 3, Human | 1 | 2021 | 159 | 0.700 |
Why?
|
Anti-Bacterial Agents | 9 | 2024 | 7475 | 0.670 |
Why?
|
Anti-Infective Agents | 5 | 2022 | 987 | 0.660 |
Why?
|
Bacteremia | 2 | 2024 | 987 | 0.650 |
Why?
|
Ganciclovir | 6 | 2024 | 256 | 0.640 |
Why?
|
Herpes Simplex | 1 | 2022 | 470 | 0.640 |
Why?
|
Humans | 163 | 2024 | 766766 | 0.640 |
Why?
|
Dengue | 1 | 2022 | 258 | 0.630 |
Why?
|
DNA Virus Infections | 1 | 2018 | 15 | 0.630 |
Why?
|
Practice Guidelines as Topic | 14 | 2024 | 7431 | 0.620 |
Why?
|
Torque teno virus | 1 | 2018 | 13 | 0.620 |
Why?
|
Advisory Committees | 8 | 2024 | 797 | 0.600 |
Why?
|
Living Donors | 2 | 2021 | 647 | 0.590 |
Why?
|
Influenza Vaccines | 5 | 2012 | 780 | 0.570 |
Why?
|
Latent Tuberculosis | 3 | 2021 | 223 | 0.570 |
Why?
|
Disease Outbreaks | 2 | 2024 | 1761 | 0.570 |
Why?
|
Graft Rejection | 7 | 2022 | 4504 | 0.560 |
Why?
|
Disease Transmission, Infectious | 6 | 2017 | 560 | 0.550 |
Why?
|
Tuberculosis | 3 | 2023 | 2011 | 0.550 |
Why?
|
Propensity Score | 1 | 2024 | 1972 | 0.530 |
Why?
|
Cytomegalovirus Vaccines | 2 | 2020 | 20 | 0.510 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1885 | 0.490 |
Why?
|
Monitoring, Immunologic | 2 | 2013 | 99 | 0.490 |
Why?
|
Dichlororibofuranosylbenzimidazole | 2 | 2024 | 16 | 0.460 |
Why?
|
Encephalitozoonosis | 1 | 2014 | 2 | 0.460 |
Why?
|
Encephalitozoon cuniculi | 1 | 2014 | 5 | 0.460 |
Why?
|
Hepatitis E | 1 | 2015 | 76 | 0.460 |
Why?
|
Quinazolines | 2 | 2021 | 1367 | 0.460 |
Why?
|
Enzyme-Linked Immunospot Assay | 3 | 2022 | 126 | 0.450 |
Why?
|
Ribonucleosides | 2 | 2024 | 79 | 0.450 |
Why?
|
Budd-Chiari Syndrome | 1 | 2013 | 24 | 0.440 |
Why?
|
Ribavirin | 1 | 2015 | 396 | 0.440 |
Why?
|
Pandemics | 8 | 2024 | 8735 | 0.420 |
Why?
|
Drug Resistance, Viral | 8 | 2024 | 868 | 0.420 |
Why?
|
Jaundice | 1 | 2013 | 95 | 0.410 |
Why?
|
Epidemics | 1 | 2018 | 516 | 0.400 |
Why?
|
Aspergillosis | 2 | 2019 | 242 | 0.390 |
Why?
|
Vancomycin Resistance | 1 | 2012 | 125 | 0.390 |
Why?
|
Enterococcus faecium | 1 | 2012 | 101 | 0.380 |
Why?
|
Mycobacterium kansasii | 1 | 2011 | 8 | 0.380 |
Why?
|
Transplants | 4 | 2022 | 209 | 0.380 |
Why?
|
Clonorchis sinensis | 1 | 2010 | 3 | 0.370 |
Why?
|
Alternaria | 1 | 2011 | 41 | 0.360 |
Why?
|
Liver Abscess | 1 | 2011 | 81 | 0.360 |
Why?
|
Influenza, Human | 5 | 2017 | 1543 | 0.360 |
Why?
|
Adenovirus Infections, Human | 1 | 2011 | 76 | 0.350 |
Why?
|
Trichophyton | 1 | 2010 | 21 | 0.350 |
Why?
|
Malacoplakia | 2 | 2021 | 15 | 0.350 |
Why?
|
Meningitis, Bacterial | 1 | 2012 | 222 | 0.350 |
Why?
|
Pancreas Transplantation | 1 | 2011 | 194 | 0.340 |
Why?
|
Salmonella Vaccines | 2 | 2006 | 9 | 0.340 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2012 | 340 | 0.340 |
Why?
|
Transplantation | 3 | 2017 | 222 | 0.330 |
Why?
|
Postoperative Complications | 7 | 2022 | 15831 | 0.320 |
Why?
|
Antiparasitic Agents | 3 | 2018 | 41 | 0.320 |
Why?
|
Aspergillus | 2 | 2015 | 93 | 0.320 |
Why?
|
Markov Chains | 1 | 2013 | 974 | 0.320 |
Why?
|
Immunization | 5 | 2023 | 1218 | 0.320 |
Why?
|
Hepatitis B, Chronic | 1 | 2013 | 413 | 0.310 |
Why?
|
Nephrotic Syndrome | 1 | 2013 | 381 | 0.310 |
Why?
|
End Stage Liver Disease | 1 | 2013 | 369 | 0.310 |
Why?
|
Risk Factors | 26 | 2024 | 74881 | 0.310 |
Why?
|
Cytosine | 2 | 2022 | 212 | 0.310 |
Why?
|
Hemochromatosis | 1 | 2010 | 175 | 0.310 |
Why?
|
Cecum | 1 | 2009 | 231 | 0.310 |
Why?
|
Schistosomiasis mansoni | 1 | 2009 | 94 | 0.310 |
Why?
|
Steroids | 2 | 2013 | 936 | 0.300 |
Why?
|
Schistosoma mansoni | 1 | 2009 | 156 | 0.300 |
Why?
|
Preventive Health Services | 1 | 2013 | 571 | 0.300 |
Why?
|
Bacterial Infections | 2 | 2014 | 1390 | 0.290 |
Why?
|
Respiratory Tract Diseases | 2 | 2023 | 744 | 0.290 |
Why?
|
Tissue and Organ Harvesting | 1 | 2010 | 373 | 0.290 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2008 | 113 | 0.280 |
Why?
|
Zoonoses | 2 | 2007 | 180 | 0.270 |
Why?
|
Adenoviridae | 1 | 2011 | 1093 | 0.270 |
Why?
|
Coccidioides | 1 | 2006 | 17 | 0.260 |
Why?
|
Coccidioidomycosis | 1 | 2006 | 36 | 0.260 |
Why?
|
Antifungal Agents | 3 | 2019 | 769 | 0.250 |
Why?
|
Gene Products, gag | 1 | 2006 | 317 | 0.250 |
Why?
|
Heart Transplantation | 5 | 2021 | 3306 | 0.250 |
Why?
|
Treatment Outcome | 15 | 2024 | 65273 | 0.250 |
Why?
|
Hand | 1 | 2011 | 909 | 0.250 |
Why?
|
Renal Dialysis | 3 | 2024 | 1790 | 0.240 |
Why?
|
Adult | 40 | 2024 | 223307 | 0.240 |
Why?
|
Bacteriological Techniques | 1 | 2006 | 277 | 0.240 |
Why?
|
Salmonella Infections | 1 | 2006 | 175 | 0.240 |
Why?
|
Salmonella typhi | 1 | 2006 | 202 | 0.230 |
Why?
|
Trypanosoma cruzi | 2 | 2018 | 204 | 0.230 |
Why?
|
Blood Safety | 1 | 2024 | 16 | 0.230 |
Why?
|
Registries | 2 | 2018 | 8351 | 0.220 |
Why?
|
Measles Vaccine | 1 | 2024 | 79 | 0.220 |
Why?
|
Benzimidazoles | 3 | 2024 | 862 | 0.220 |
Why?
|
Salmonella typhimurium | 1 | 2006 | 348 | 0.220 |
Why?
|
Hepatitis B virus | 3 | 2017 | 531 | 0.220 |
Why?
|
Cephalosporins | 1 | 2024 | 200 | 0.210 |
Why?
|
Male | 42 | 2024 | 364142 | 0.210 |
Why?
|
Endemic Diseases | 2 | 2018 | 190 | 0.210 |
Why?
|
Foscarnet | 1 | 2022 | 36 | 0.210 |
Why?
|
Chemoprevention | 2 | 2023 | 327 | 0.210 |
Why?
|
HIV Seropositivity | 1 | 2008 | 962 | 0.200 |
Why?
|
Immunization Schedule | 3 | 2023 | 229 | 0.200 |
Why?
|
Middle Aged | 35 | 2024 | 223257 | 0.200 |
Why?
|
beta-Lactamases | 1 | 2024 | 308 | 0.200 |
Why?
|
Acyclovir | 1 | 2022 | 266 | 0.190 |
Why?
|
Administration, Oral | 2 | 2024 | 4018 | 0.190 |
Why?
|
Hepatitis B | 3 | 2017 | 709 | 0.190 |
Why?
|
Hepatitis C, Chronic | 2 | 2020 | 1033 | 0.190 |
Why?
|
Herpes Zoster Vaccine | 1 | 2022 | 49 | 0.190 |
Why?
|
Rectum | 1 | 2006 | 896 | 0.190 |
Why?
|
Protozoan Vaccines | 2 | 2012 | 13 | 0.190 |
Why?
|
Anthozoa | 1 | 2021 | 65 | 0.180 |
Why?
|
Liver | 4 | 2013 | 7571 | 0.180 |
Why?
|
Infection Control | 1 | 2008 | 984 | 0.180 |
Why?
|
Serotonin Syndrome | 1 | 2020 | 18 | 0.180 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2022 | 241 | 0.180 |
Why?
|
Hemofiltration | 1 | 2021 | 58 | 0.180 |
Why?
|
Histoplasmosis | 1 | 2020 | 63 | 0.180 |
Why?
|
Nephrology | 1 | 2024 | 270 | 0.170 |
Why?
|
Neoplasms | 8 | 2021 | 22350 | 0.170 |
Why?
|
AIDS Vaccines | 1 | 2006 | 898 | 0.170 |
Why?
|
Azithromycin | 1 | 2021 | 201 | 0.170 |
Why?
|
Viremia | 2 | 2023 | 727 | 0.170 |
Why?
|
Intestines | 2 | 2009 | 1904 | 0.170 |
Why?
|
Liver Cirrhosis | 1 | 2010 | 1960 | 0.160 |
Why?
|
Microbiological Techniques | 1 | 2020 | 97 | 0.160 |
Why?
|
Antibiotic Prophylaxis | 3 | 2022 | 641 | 0.160 |
Why?
|
Vaccines, Attenuated | 3 | 2011 | 314 | 0.160 |
Why?
|
Feces | 1 | 2006 | 1505 | 0.160 |
Why?
|
Clinical Trials as Topic | 3 | 2024 | 8045 | 0.160 |
Why?
|
Herpes Zoster | 1 | 2022 | 252 | 0.160 |
Why?
|
T-Lymphocytes | 2 | 2019 | 10264 | 0.160 |
Why?
|
Mycoses | 1 | 2022 | 389 | 0.160 |
Why?
|
Biopsy | 5 | 2013 | 6779 | 0.160 |
Why?
|
Isoniazid | 1 | 2020 | 279 | 0.160 |
Why?
|
Death | 2 | 2018 | 685 | 0.160 |
Why?
|
Pneumonia | 2 | 2024 | 2159 | 0.160 |
Why?
|
Antigens | 1 | 2004 | 1441 | 0.160 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 3804 | 0.160 |
Why?
|
Bacterial Vaccines | 2 | 2012 | 400 | 0.150 |
Why?
|
Female | 31 | 2024 | 396520 | 0.150 |
Why?
|
Mass Screening | 2 | 2021 | 5454 | 0.150 |
Why?
|
Viral Matrix Proteins | 1 | 2019 | 193 | 0.150 |
Why?
|
Drug Approval | 2 | 2022 | 820 | 0.150 |
Why?
|
Simplexvirus | 1 | 2021 | 805 | 0.140 |
Why?
|
Viral Vaccines | 2 | 2013 | 596 | 0.140 |
Why?
|
United States | 19 | 2024 | 72951 | 0.140 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2013 | 4056 | 0.140 |
Why?
|
Urinary Tract Infections | 1 | 2024 | 804 | 0.140 |
Why?
|
Blood Transfusion | 1 | 2024 | 1308 | 0.140 |
Why?
|
Rhodococcus | 1 | 2017 | 13 | 0.140 |
Why?
|
Attitude of Health Personnel | 1 | 2011 | 3927 | 0.140 |
Why?
|
Quality-Adjusted Life Years | 1 | 2024 | 1740 | 0.140 |
Why?
|
Actinomycetales Infections | 1 | 2017 | 30 | 0.140 |
Why?
|
Sequence Analysis, DNA | 2 | 2023 | 4780 | 0.140 |
Why?
|
Escherichia coli Infections | 1 | 2021 | 518 | 0.140 |
Why?
|
Incidence | 5 | 2024 | 21525 | 0.140 |
Why?
|
Pseudomonas aeruginosa | 1 | 2024 | 1276 | 0.130 |
Why?
|
Diarrhea | 1 | 2023 | 1317 | 0.130 |
Why?
|
Polymyxins | 1 | 2016 | 17 | 0.130 |
Why?
|
Candidemia | 1 | 2017 | 46 | 0.130 |
Why?
|
Trimethoprim | 1 | 2016 | 79 | 0.130 |
Why?
|
Immediate-Early Proteins | 1 | 2019 | 444 | 0.130 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2022 | 1642 | 0.130 |
Why?
|
Chagas Disease | 1 | 2018 | 166 | 0.130 |
Why?
|
Prospective Studies | 7 | 2024 | 54871 | 0.130 |
Why?
|
Triazoles | 2 | 2019 | 902 | 0.130 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2010 | 2429 | 0.130 |
Why?
|
Respiratory Tract Infections | 1 | 2023 | 1008 | 0.130 |
Why?
|
Bacteria | 2 | 2017 | 2212 | 0.120 |
Why?
|
Immunomodulation | 2 | 2021 | 548 | 0.120 |
Why?
|
Neuroaspergillosis | 1 | 2015 | 3 | 0.120 |
Why?
|
Risk Assessment | 8 | 2018 | 24295 | 0.120 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2015 | 23 | 0.120 |
Why?
|
Chagas Cardiomyopathy | 1 | 2015 | 72 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2024 | 2060 | 0.120 |
Why?
|
Drug Prescriptions | 1 | 2024 | 1663 | 0.120 |
Why?
|
West Nile Fever | 1 | 2015 | 77 | 0.120 |
Why?
|
West Nile virus | 1 | 2015 | 77 | 0.120 |
Why?
|
Retrospective Studies | 11 | 2024 | 81635 | 0.120 |
Why?
|
Health Resources | 1 | 2020 | 951 | 0.110 |
Why?
|
Aged | 19 | 2024 | 171343 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1794 | 0.110 |
Why?
|
Tacrolimus | 2 | 2022 | 753 | 0.110 |
Why?
|
Patient Education as Topic | 1 | 2024 | 2334 | 0.110 |
Why?
|
Antitubercular Agents | 2 | 2012 | 1380 | 0.110 |
Why?
|
Cost-Benefit Analysis | 3 | 2024 | 5536 | 0.110 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2014 | 75 | 0.110 |
Why?
|
Sudan | 1 | 2013 | 86 | 0.110 |
Why?
|
Immune System | 1 | 2019 | 800 | 0.110 |
Why?
|
Nitriles | 1 | 2019 | 981 | 0.110 |
Why?
|
Virginiamycin | 1 | 2012 | 11 | 0.100 |
Why?
|
Societies, Medical | 5 | 2019 | 3957 | 0.100 |
Why?
|
Bacterial Proteins | 1 | 2006 | 3833 | 0.100 |
Why?
|
International Agencies | 1 | 2013 | 244 | 0.100 |
Why?
|
Herpesvirus 6, Human | 1 | 2013 | 96 | 0.100 |
Why?
|
Hepatitis C | 2 | 2020 | 1595 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6512 | 0.100 |
Why?
|
Hepatorenal Syndrome | 1 | 2013 | 76 | 0.100 |
Why?
|
Daptomycin | 1 | 2012 | 71 | 0.100 |
Why?
|
Oxazolidinones | 1 | 2012 | 99 | 0.100 |
Why?
|
Cryptosporidiosis | 1 | 2012 | 52 | 0.100 |
Why?
|
Facial Transplantation | 1 | 2014 | 220 | 0.090 |
Why?
|
Mycological Typing Techniques | 1 | 2011 | 9 | 0.090 |
Why?
|
DNA, Ribosomal Spacer | 1 | 2011 | 27 | 0.090 |
Why?
|
Graft Survival | 3 | 2013 | 3904 | 0.090 |
Why?
|
Clonorchiasis | 1 | 2010 | 5 | 0.090 |
Why?
|
Microbial Sensitivity Tests | 2 | 2021 | 1972 | 0.090 |
Why?
|
ROC Curve | 1 | 2019 | 3620 | 0.090 |
Why?
|
Maxilla | 1 | 2014 | 486 | 0.090 |
Why?
|
Antibody Formation | 3 | 2023 | 1392 | 0.090 |
Why?
|
Viral Core Proteins | 1 | 2011 | 158 | 0.090 |
Why?
|
Communicable Disease Control | 1 | 2017 | 857 | 0.090 |
Why?
|
Acetamides | 1 | 2012 | 260 | 0.090 |
Why?
|
Enteritis | 1 | 2012 | 162 | 0.090 |
Why?
|
Prosthesis-Related Infections | 1 | 2016 | 497 | 0.090 |
Why?
|
Leukemia Virus, Murine | 1 | 2010 | 95 | 0.090 |
Why?
|
Length of Stay | 1 | 2024 | 6490 | 0.090 |
Why?
|
Retroviridae Infections | 1 | 2010 | 148 | 0.090 |
Why?
|
Subcutaneous Tissue | 1 | 2011 | 131 | 0.090 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 668 | 0.090 |
Why?
|
DNA, Fungal | 1 | 2011 | 275 | 0.080 |
Why?
|
Caregivers | 1 | 2022 | 2303 | 0.080 |
Why?
|
Fatal Outcome | 3 | 2009 | 1838 | 0.080 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1404 | 0.080 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2010 | 168 | 0.080 |
Why?
|
Interferon-gamma | 2 | 2023 | 3158 | 0.080 |
Why?
|
Adaptive Immunity | 1 | 2014 | 734 | 0.080 |
Why?
|
Vaccines, Synthetic | 2 | 2022 | 620 | 0.080 |
Why?
|
Listeria monocytogenes | 1 | 2011 | 245 | 0.080 |
Why?
|
Fungal Vaccines | 1 | 2008 | 7 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2565 | 0.080 |
Why?
|
Histocytochemistry | 1 | 2010 | 697 | 0.080 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2010 | 217 | 0.080 |
Why?
|
HIV-1 | 1 | 2006 | 6948 | 0.080 |
Why?
|
Genetic Vectors | 2 | 2011 | 3401 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1946 | 0.080 |
Why?
|
Debridement | 1 | 2011 | 494 | 0.070 |
Why?
|
Comorbidity | 2 | 2021 | 10580 | 0.070 |
Why?
|
Hepacivirus | 3 | 2020 | 1343 | 0.070 |
Why?
|
Tachycardia, Sinus | 1 | 1997 | 43 | 0.070 |
Why?
|
Cross Infection | 1 | 2017 | 1427 | 0.070 |
Why?
|
Immunity, Mucosal | 1 | 2011 | 498 | 0.070 |
Why?
|
Young Adult | 7 | 2021 | 59939 | 0.070 |
Why?
|
Transplantation Immunology | 2 | 2010 | 540 | 0.070 |
Why?
|
Amlodipine | 1 | 1997 | 84 | 0.070 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2021 | 335 | 0.070 |
Why?
|
Nucleic Acids | 1 | 2010 | 189 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2013 | 811 | 0.070 |
Why?
|
Disease Vectors | 1 | 2007 | 61 | 0.070 |
Why?
|
Pyridines | 1 | 2019 | 2888 | 0.070 |
Why?
|
Peptides | 1 | 2019 | 4344 | 0.070 |
Why?
|
Antibodies, Viral | 3 | 2023 | 3212 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2017 | 2779 | 0.070 |
Why?
|
HIV Core Protein p24 | 1 | 2006 | 245 | 0.060 |
Why?
|
Heart | 1 | 2019 | 4425 | 0.060 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2013 | 790 | 0.060 |
Why?
|
U937 Cells | 1 | 2006 | 260 | 0.060 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2006 | 361 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2009 | 12985 | 0.060 |
Why?
|
Serologic Tests | 2 | 2018 | 382 | 0.060 |
Why?
|
Brain Death | 1 | 2009 | 360 | 0.060 |
Why?
|
Fibrosis | 1 | 2013 | 2077 | 0.060 |
Why?
|
Brain Diseases | 1 | 2015 | 1552 | 0.060 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2006 | 140 | 0.060 |
Why?
|
Animals | 10 | 2021 | 168930 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2008 | 308 | 0.060 |
Why?
|
Coma | 1 | 2009 | 485 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2014 | 1594 | 0.060 |
Why?
|
Heart-Assist Devices | 1 | 2016 | 1287 | 0.060 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2006 | 176 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9244 | 0.060 |
Why?
|
North America | 2 | 2022 | 1287 | 0.060 |
Why?
|
Child | 8 | 2017 | 80668 | 0.060 |
Why?
|
Pulmonary Edema | 1 | 1997 | 409 | 0.060 |
Why?
|
Preoperative Care | 1 | 2013 | 2253 | 0.060 |
Why?
|
Calcium Channel Blockers | 1 | 1997 | 687 | 0.060 |
Why?
|
Drug Monitoring | 2 | 2021 | 962 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2010 | 1362 | 0.050 |
Why?
|
International Cooperation | 1 | 2010 | 1434 | 0.050 |
Why?
|
Babesia microti | 1 | 2003 | 31 | 0.050 |
Why?
|
United States Food and Drug Administration | 2 | 2022 | 1673 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2013 | 1434 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3110 | 0.050 |
Why?
|
Immune System Diseases | 1 | 2005 | 253 | 0.050 |
Why?
|
New England | 1 | 2006 | 1059 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3232 | 0.050 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 2010 | 0.050 |
Why?
|
Emigrants and Immigrants | 1 | 2009 | 550 | 0.050 |
Why?
|
Babesiosis | 1 | 2003 | 92 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15416 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1884 | 0.050 |
Why?
|
Borrelia burgdorferi | 1 | 2003 | 183 | 0.050 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2024 | 434 | 0.050 |
Why?
|
CDC2 Protein Kinase | 1 | 1992 | 212 | 0.050 |
Why?
|
Specimen Handling | 1 | 2006 | 706 | 0.050 |
Why?
|
Flucytosine | 1 | 2021 | 31 | 0.050 |
Why?
|
Hypotension | 1 | 1997 | 887 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2020 | 1331 | 0.050 |
Why?
|
Histoplasma | 1 | 2020 | 40 | 0.050 |
Why?
|
Infant | 4 | 2023 | 36461 | 0.040 |
Why?
|
Causality | 1 | 2007 | 1252 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 2413 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2022 | 349 | 0.040 |
Why?
|
Cyclosporine | 1 | 2022 | 778 | 0.040 |
Why?
|
Ultrasonography | 1 | 2013 | 5992 | 0.040 |
Why?
|
Cell Cycle | 2 | 1992 | 2926 | 0.040 |
Why?
|
Primary Prevention | 1 | 2007 | 1188 | 0.040 |
Why?
|
Multigene Family | 1 | 1992 | 1081 | 0.040 |
Why?
|
Heart Arrest | 1 | 2009 | 1516 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2022 | 6307 | 0.040 |
Why?
|
Amino Acid Sequence | 4 | 2006 | 13411 | 0.040 |
Why?
|
Transplantation, Homologous | 2 | 2022 | 4860 | 0.040 |
Why?
|
Capsules | 1 | 2019 | 192 | 0.040 |
Why?
|
Recurrence | 2 | 2015 | 8507 | 0.040 |
Why?
|
Prognosis | 2 | 2011 | 29948 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14652 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3692 | 0.040 |
Why?
|
Isoantibodies | 1 | 2022 | 681 | 0.040 |
Why?
|
Molecular Sequence Data | 4 | 2006 | 17608 | 0.040 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2021 | 497 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 892 | 0.040 |
Why?
|
Internship and Residency | 1 | 2018 | 5943 | 0.040 |
Why?
|
Prevalence | 1 | 2015 | 15835 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2006 | 3738 | 0.040 |
Why?
|
Developing Countries | 2 | 2013 | 2913 | 0.040 |
Why?
|
Pyrrolidines | 1 | 2019 | 339 | 0.040 |
Why?
|
Lyme Disease | 1 | 2003 | 627 | 0.040 |
Why?
|
Quinoxalines | 1 | 2019 | 297 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 6222 | 0.040 |
Why?
|
Drug Resistance, Microbial | 1 | 2020 | 832 | 0.040 |
Why?
|
Odds Ratio | 2 | 2021 | 9661 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4252 | 0.030 |
Why?
|
Time Factors | 3 | 2018 | 40149 | 0.030 |
Why?
|
Brain | 2 | 2019 | 27159 | 0.030 |
Why?
|
Jejunum | 1 | 2019 | 474 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2022 | 789 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 2018 | 492 | 0.030 |
Why?
|
Latin America | 1 | 2018 | 416 | 0.030 |
Why?
|
Skin | 1 | 2010 | 4499 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2013 | 4282 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2018 | 794 | 0.030 |
Why?
|
Child, Preschool | 4 | 2017 | 42577 | 0.030 |
Why?
|
Nifurtimox | 1 | 2015 | 14 | 0.030 |
Why?
|
Carbapenems | 1 | 2017 | 125 | 0.030 |
Why?
|
Host-Parasite Interactions | 1 | 2018 | 303 | 0.030 |
Why?
|
Trypanocidal Agents | 1 | 2015 | 40 | 0.030 |
Why?
|
Polymerase Chain Reaction | 4 | 2013 | 6066 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 614 | 0.030 |
Why?
|
Aspergillus flavus | 1 | 2015 | 13 | 0.030 |
Why?
|
Scedosporium | 1 | 2015 | 10 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2017 | 957 | 0.030 |
Why?
|
Hepatitis B Core Antigens | 1 | 2015 | 90 | 0.030 |
Why?
|
DNA, Viral | 2 | 2013 | 2201 | 0.030 |
Why?
|
DNA, Protozoan | 1 | 2015 | 227 | 0.030 |
Why?
|
Nitroimidazoles | 1 | 2015 | 118 | 0.030 |
Why?
|
Waiting Lists | 1 | 2019 | 779 | 0.030 |
Why?
|
Hepatitis B Antibodies | 1 | 2015 | 156 | 0.030 |
Why?
|
Acute Disease | 1 | 2005 | 7241 | 0.030 |
Why?
|
Health Care Costs | 1 | 2007 | 3242 | 0.030 |
Why?
|
Curriculum | 2 | 2018 | 3783 | 0.030 |
Why?
|
Administration, Topical | 1 | 2016 | 702 | 0.030 |
Why?
|
India | 1 | 2020 | 2335 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2018 | 642 | 0.030 |
Why?
|
Lamivudine | 1 | 2015 | 367 | 0.030 |
Why?
|
Oropharynx | 1 | 2014 | 139 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2010 | 7868 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2085 | 0.030 |
Why?
|
Canada | 1 | 2018 | 2126 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2659 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2019 | 802 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3385 | 0.020 |
Why?
|
Adolescent | 4 | 2021 | 88904 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2019 | 1540 | 0.020 |
Why?
|
Cohort Studies | 3 | 2021 | 41710 | 0.020 |
Why?
|
DNA | 2 | 2024 | 7208 | 0.020 |
Why?
|
Paranasal Sinuses | 1 | 2014 | 267 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2020 | 1600 | 0.020 |
Why?
|
Nucleocapsid Proteins | 1 | 2011 | 75 | 0.020 |
Why?
|
European Union | 1 | 2012 | 158 | 0.020 |
Why?
|
Geography | 1 | 2013 | 651 | 0.020 |
Why?
|
Hemolysin Proteins | 1 | 2011 | 113 | 0.020 |
Why?
|
HIV | 1 | 2017 | 1588 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20708 | 0.020 |
Why?
|
Sulfonamides | 1 | 2019 | 1982 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2232 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 13036 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 2018 | 1134 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2017 | 1065 | 0.020 |
Why?
|
Vaccines, Inactivated | 1 | 2009 | 186 | 0.020 |
Why?
|
Escherichia coli | 1 | 2021 | 4211 | 0.020 |
Why?
|
Hemodynamics | 1 | 2019 | 4188 | 0.020 |
Why?
|
HIV Infections | 3 | 2017 | 17536 | 0.020 |
Why?
|
Fever | 2 | 2008 | 1607 | 0.020 |
Why?
|
Genes, p53 | 1 | 1990 | 711 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3384 | 0.020 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 1990 | 249 | 0.020 |
Why?
|
Neutropenia | 1 | 2013 | 894 | 0.020 |
Why?
|
Phylogeny | 1 | 2015 | 2840 | 0.020 |
Why?
|
Internationality | 1 | 2013 | 1006 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3799 | 0.020 |
Why?
|
Splenomegaly | 1 | 2008 | 191 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 792 | 0.020 |
Why?
|
Pancytopenia | 1 | 2008 | 102 | 0.020 |
Why?
|
Lung | 2 | 2021 | 10067 | 0.020 |
Why?
|
Neurology | 1 | 2014 | 785 | 0.020 |
Why?
|
Europe | 1 | 2013 | 3430 | 0.020 |
Why?
|
Arenaviridae Infections | 1 | 2006 | 53 | 0.020 |
Why?
|
Diagnosis-Related Groups | 1 | 2007 | 445 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2008 | 354 | 0.020 |
Why?
|
Bacterial Toxins | 1 | 2011 | 922 | 0.020 |
Why?
|
Resource Allocation | 1 | 2007 | 354 | 0.020 |
Why?
|
Virus Replication | 1 | 2013 | 2457 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2015 | 2006 | 0.010 |
Why?
|
Osteosarcoma | 1 | 1990 | 908 | 0.010 |
Why?
|
Social Class | 1 | 2013 | 2007 | 0.010 |
Why?
|
Erythrocyte Inclusions | 1 | 2003 | 4 | 0.010 |
Why?
|
Mutation | 2 | 2024 | 30213 | 0.010 |
Why?
|
Hematologic Diseases | 1 | 2008 | 502 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6968 | 0.010 |
Why?
|
Mice | 2 | 2011 | 81889 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 1990 | 2948 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2013 | 2234 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2006 | 2551 | 0.010 |
Why?
|
Sweating | 1 | 2003 | 155 | 0.010 |
Why?
|
Cricetinae | 1 | 2006 | 2416 | 0.010 |
Why?
|
Anemia, Hemolytic | 1 | 2003 | 164 | 0.010 |
Why?
|
Cloning, Molecular | 2 | 1992 | 4168 | 0.010 |
Why?
|
Urine | 1 | 2003 | 363 | 0.010 |
Why?
|
Pharyngitis | 1 | 2003 | 221 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 1992 | 556 | 0.010 |
Why?
|
Clinical Competence | 1 | 2017 | 4858 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 30237 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2008 | 1069 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18397 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1992 | 1057 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10823 | 0.010 |
Why?
|
Mycobacterium tuberculosis | 1 | 2012 | 1911 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 1992 | 747 | 0.010 |
Why?
|
Sarcoma | 1 | 1990 | 1802 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2011 | 4559 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22248 | 0.010 |
Why?
|
Critical Care | 1 | 2011 | 2714 | 0.010 |
Why?
|
Suicide, Attempted | 1 | 1997 | 1413 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 36567 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39309 | 0.010 |
Why?
|
Massachusetts | 1 | 2010 | 8891 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 1992 | 1741 | 0.010 |
Why?
|
HeLa Cells | 1 | 1992 | 3073 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59550 | 0.010 |
Why?
|
Dyspnea | 1 | 2003 | 1352 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2010 | 3788 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 14072 | 0.010 |
Why?
|
Erythrocytes | 1 | 2003 | 2412 | 0.010 |
Why?
|
Cell Line | 2 | 1992 | 15563 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 1992 | 2678 | 0.010 |
Why?
|
Kidney | 1 | 2006 | 7074 | 0.010 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1990 | 167 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1990 | 848 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1990 | 766 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 26310 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1990 | 418 | 0.010 |
Why?
|
Codon | 1 | 1990 | 599 | 0.000 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1990 | 781 | 0.000 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1990 | 1677 | 0.000 |
Why?
|
Germ Cells | 1 | 1990 | 645 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1990 | 2470 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1990 | 21162 | 0.000 |
Why?
|
Pedigree | 1 | 1990 | 4539 | 0.000 |
Why?
|
Transfection | 1 | 1990 | 5754 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1990 | 5890 | 0.000 |
Why?
|
Base Sequence | 1 | 1990 | 12415 | 0.000 |
Why?
|
Genetic Testing | 1 | 1990 | 3591 | 0.000 |
Why?
|